AlphaCentric Advisors LLC

SEC CIK: 0001913464
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

XERS holding history

Xeris Biopharma Holdings, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XERS overview All 13F holders of XERS Full Q2 2026 holdings

Shares (Q2 2026): 46,549
Value: $368.7K
% of portfolio: 0.3%
Quarters held: 3; Since Q4 2025

Holdings of XERS by AlphaCentric Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	46,549	$368.7K	0.3%	+663+1.4%	Added	Holders
Q1 2026	45,886	$266.1K	0.3%	+2,494+5.7%	Added	Holders
Q4 2025	43,392	$340.6K	0.3%	–	No prior filing	Holders